Compare
Nu-Med Plus, Inc. vs Northern Minerals & Exploration Ltd. vs Atlas Critical Minerals Corp vs Blusky AI Inc.
| Latest fiscal year | Nu-Med Plus, Inc. NUMD | Northern Minerals & Exploration Ltd. NMEX | Atlas Critical Minerals Corp ATCX | Blusky AI Inc. BSAI |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-07-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $30.6K | $92.5K | n/a |
| Revenue growth (YoY) | n/a | +254.4% | -86.1% | n/a |
| Gross margin | n/a | -23.9% | -64.3% | n/a |
| Operating margin | n/a | -965.2% | n/m | n/a |
| Net margin | n/a | n/m | n/m | n/a |
| Net income | -$56.2K | -$474.9K | -$5.42M | -$4.52M |
| EPS (Diluted) | $0.00 | n/a | -$1.69 | -$0.96 |
| Operating cash flow | -$48.0K | -$283.4K | -$2.98M | -$1.16M |
| Free cash flow | n/a | n/a | -$3.12M | n/a |
| Cash & equivalents | n/a | n/a | $30.2K | $960.4K |
| Total assets | $7.9K | $84.3K | $2.65M | $2.67M |
| Total liabilities | $279.2K | $304.1K | $1.85M | $3.60M |
| Shareholders' equity | -$271.3K | -$219.8K | $804.5K | -$930.5K |
| Return on year-end equity | n/a | n/a | -673.8% | n/a |
| Shares outstanding | 83.55M | 120.03M | 3.47M | 24.98M |
Revenue, most recent five fiscal years
| Fiscal year | Nu-Med Plus, Inc. | Northern Minerals & Exploration Ltd. | Atlas Critical Minerals Corp | Blusky AI Inc. |
|---|---|---|---|---|
| Latest | $0 Ended 2020-12-31 | $30.6K Ended 2026-07-31 | $92.5K Ended 2025-12-31 | $4.73M Ended 2021-12-31 |
| 1 year earlier | $0 Ended 2019-12-31 | $8.6K Ended 2025-07-31 | $667.1K Ended 2024-12-31 | $4.14M Ended 2020-12-31 |
| 2 years earlier | $0 Ended 2018-12-31 | $0 Ended 2024-07-31 | n/a | n/a |
| 3 years earlier | $0 Ended 2017-12-31 | n/a | n/a | n/a |
| 4 years earlier | $0 Ended 2016-12-31 | n/a | n/a | n/a |